← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Forsyth Institute
Cambridge, MA
$61,896,909
Total funding
76
Grants
Funding mix
By agency
NIH$61,896,909 · 76
By mechanism
R01$44,222,344 · 31
P01$4,442,201 · 9
R37$4,187,800 · 2
R21$1,746,674 · 4
K22$1,549,169 · 4
R29$1,026,913 · 4
Investigators at Forsyth Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
CONTROL OF PERIODONTAL INFECTIONS$1,277,464
P01 · FY2003 · DE
Biologic Basis of Refractory Periodontal Disease$1,208,723
R01 · FY2005 · DE
Biologic Basis of Refractory Periodontal Disease$1,188,290
R01 · FY2003 · DE
Biologic Basis of Refractory Periodontal Disease$1,173,979
R01 · FY2004 · DE
CONTROL OF PERIODONTAL INFECTIONS$1,158,142
P01 · FY2002 · DE
CONTROL OF PERIODONTAL INFECTIONS$1,130,207
P01 · FY2001 · DE
Biologic Basis of Refractory Periodontal Disease$1,110,968
R01 · FY2002 · DE
CONTROL OF PERIODONTAL INFECTIONS$1,106,416
P01 · FY2000 · DE
CELLULAR AND MOLECULAR CONTROLS OF BIOMINERALIZATION$1,062,740
P01 · FY2002 · DE
CELLULAR AND MOLECULAR CONTROLS OF BIOMINERALIZATION$1,040,851
P01 · FY2003 · DE
CELLULAR AND MOLECULAR CONTROLS OF BIOMINERALIZATION$952,643
P01 · FY2001 · DE
CELLULAR AND MOLECULAR CONTROLS OF BIOMINERALIZATION$933,342
P01 · FY2000 · DE
INITIAL LESION OF ADULT PERIODONTITIS$751,081
R01 · FY2000 · DE
INITIAL LESION OF ADULT PERIODONTITIS$651,408
R01 · FY2002 · DE
BOSTON ORAL HEALTH CLINICAL RESOURCE CENTER$630,943
P30 · FY2000 · DE
INITIAL LESION OF ADULT PERIODONTITIS$619,356
R01 · FY2001 · DE
Three Periodontal Therapies in Current &Non-Smokers$609,364
R01 · FY2005 · DE
Three Periodontal Therapies in Current &Non-Smokers$592,437
R01 · FY2004 · DE
Intra-Oral Biofilm Formation$584,941
R01 · FY2004 · DE
Three Periodontal Therapies in Current &Non-Smokers$575,613
R01 · FY2003 · DE